HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$29.70
Day range
$28.65 - $29.30
Year range
$10.60 - $31.82
Market cap
3.08B USD
Avg Volume
962.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.98M | 22.92% |
Net income | -50.22M | -26.61% |
Net profit margin | — | — |
Earnings per share | -0.47 | -11.90% |
EBITDA | -55.45M | -23.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 530.11M | 12.75% |
Total assets | 552.60M | 13.51% |
Total liabilities | 30.35M | 9.95% |
Total equity | 522.26M | — |
Shares outstanding | 107.27M | — |
Price to book | 6.04 | — |
Return on assets | -24.64% | — |
Return on capital | -25.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -50.22M | -26.61% |
Cash from operations | -38.59M | -43.16% |
Cash from investing | 49.76M | 137.85% |
Cash from financing | 3.98M | 37.31% |
Net change in cash | 15.14M | 582.32% |
Free cash flow | -56.36M | -305.92% |
About
Founded
2017
Headquarters
Website
Employees
146
